JP2023510905A5 - - Google Patents

Info

Publication number
JP2023510905A5
JP2023510905A5 JP2022543188A JP2022543188A JP2023510905A5 JP 2023510905 A5 JP2023510905 A5 JP 2023510905A5 JP 2022543188 A JP2022543188 A JP 2022543188A JP 2022543188 A JP2022543188 A JP 2022543188A JP 2023510905 A5 JP2023510905 A5 JP 2023510905A5
Authority
JP
Japan
Prior art keywords
antibody
represented
groups
trop
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022543188A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023510905A (ja
JP7781064B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/073279 external-priority patent/WO2021147993A1/zh
Publication of JP2023510905A publication Critical patent/JP2023510905A/ja
Publication of JP2023510905A5 publication Critical patent/JP2023510905A5/ja
Application granted granted Critical
Publication of JP7781064B2 publication Critical patent/JP7781064B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022543188A 2020-01-22 2021-01-22 抗trop-2抗体-エキサテカン類似体複合体及びその医薬用途 Active JP7781064B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010073438.8 2020-01-22
CN202010073438 2020-01-22
PCT/CN2021/073279 WO2021147993A1 (zh) 2020-01-22 2021-01-22 抗trop-2抗体-依喜替康类似物偶联物及其医药用途

Publications (3)

Publication Number Publication Date
JP2023510905A JP2023510905A (ja) 2023-03-15
JP2023510905A5 true JP2023510905A5 (cg-RX-API-DMAC7.html) 2024-01-31
JP7781064B2 JP7781064B2 (ja) 2025-12-05

Family

ID=76992053

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022543188A Active JP7781064B2 (ja) 2020-01-22 2021-01-22 抗trop-2抗体-エキサテカン類似体複合体及びその医薬用途

Country Status (11)

Country Link
US (1) US20230101735A1 (cg-RX-API-DMAC7.html)
EP (1) EP4095148A4 (cg-RX-API-DMAC7.html)
JP (1) JP7781064B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220130717A (cg-RX-API-DMAC7.html)
CN (3) CN118873679A (cg-RX-API-DMAC7.html)
AU (1) AU2021210074A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022014189A2 (cg-RX-API-DMAC7.html)
CA (1) CA3168260A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022008474A (cg-RX-API-DMAC7.html)
TW (1) TWI891714B (cg-RX-API-DMAC7.html)
WO (1) WO2021147993A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022078259A1 (zh) * 2020-10-12 2022-04-21 四川百利药业有限责任公司 一种氘代的喜树碱衍生物及其抗体药物偶联物
AU2022216696A1 (en) * 2021-02-05 2023-08-17 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Camptothecin compound, preparation method therefor, and application thereof
EP4349371A4 (en) 2021-06-02 2025-06-25 Bio-Thera Solutions, Ltd. DRUG CONJUGATE AND USE THEREOF
CA3225598A1 (en) * 2021-07-21 2023-01-26 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Pharmaceutical composition containing anti-trop2 antibody drug conjugate and its application
JP7767613B2 (ja) 2021-11-15 2025-11-11 システィミューン,インコーポレイテッド 二重特異性抗体-カンプトテシン薬物複合体及びその製薬的使用
US11814394B2 (en) 2021-11-16 2023-11-14 Genequantum Healthcare (Suzhou) Co., Ltd. Exatecan derivatives, linker-payloads, and conjugates and thereof
KR20240142405A (ko) * 2021-11-17 2024-09-30 씨에스피씨 메가리스 바이오파마슈티칼 씨오., 엘티디. 항체-약물 복합체 및 그의 용도
CN116212044A (zh) * 2021-12-03 2023-06-06 成都百利多特生物药业有限责任公司 抗人Trop2抗体-喜树碱类药物偶联物及其医药用途
JP2025512426A (ja) 2022-04-13 2025-04-17 ギリアード サイエンシーズ, インコーポレイテッド 腫瘍抗原発現がんを治療するための併用療法
AU2023252914A1 (en) 2022-04-13 2024-10-17 Arcus Biosciences, Inc. Combination therapy for treating trop-2 expressing cancers
WO2023214849A1 (ko) * 2022-05-04 2023-11-09 주식회사 피노바이오 Ddx5 단백질에 결합하는 캄토테신계 약물이 산 민감성 링커에 연결된 접합체 및 이를 이용한 면역접합체
JP2025519421A (ja) * 2022-06-09 2025-06-26 ベイジーン スイッツァランド ゲーエムベーハー 抗体薬物複合体
CN119421724A (zh) 2022-06-27 2025-02-11 百奥泰生物制药股份有限公司 治疗实体瘤的方法
WO2024012566A2 (en) 2022-07-15 2024-01-18 Genequantum Healthcare (Suzhou) Co., Ltd. Antibody, linkers, payload, conjugates and applications thereof
WO2024097812A1 (en) 2022-11-04 2024-05-10 Gilead Sciences, Inc. Therapy for treating bladder cancer
WO2024114318A1 (zh) * 2022-11-29 2024-06-06 四川科伦博泰生物医药股份有限公司 药物连接子化合物及其制备方法和用途
EP4653020A1 (en) 2023-01-19 2025-11-26 Shanghai Shengdi Pharmaceutical Co., Ltd Tyrosinase-mediated protein site-specific conjugation and use thereof
WO2024199343A1 (zh) * 2023-03-28 2024-10-03 江苏恒瑞医药股份有限公司 抗trop2抗体联合靶向trop2的药物治疗癌症的用途
JP2026519783A (ja) * 2023-06-05 2026-06-18 アイバイオ, インク. Trop2抗体
CN122161832A (zh) * 2023-09-08 2026-06-05 Nextpoint治疗公司 抗体-药物缀合物
WO2025179213A1 (en) * 2024-02-22 2025-08-28 Memorial Sloan-Kettering Cancer Center Targeting trop-2 in diffuse pleural mesothelioma

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US6221335B1 (en) * 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US6504029B1 (en) 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
US6440710B1 (en) * 1998-12-10 2002-08-27 The Scripps Research Institute Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
DK1104760T3 (da) * 1999-12-03 2003-06-30 Pfizer Prod Inc Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
CA2478047C (en) 2002-03-01 2014-01-21 Immunomedics, Inc. Rs7 antibodies
TW200413273A (en) * 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
ES2605443T3 (es) 2003-11-06 2017-03-14 Seattle Genetics, Inc. Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
CN101309917B (zh) * 2005-10-06 2013-09-11 奥斯拜客斯制药有限公司 具有增强治疗性质的胃h+,k+-atp酶氘代抑制剂
US7750168B2 (en) * 2006-02-10 2010-07-06 Sigma-Aldrich Co. Stabilized deuteroborane-tetrahydrofuran complex
US20100254979A1 (en) * 2009-03-06 2010-10-07 Cisthera, Incorporated Humanized PAI-1 Antibodies and Uses Thereof
JP2015506349A (ja) 2011-12-21 2015-03-02 アルデリックス, インコーポレイテッド 非全身性tgr5アゴニスト
CN104168899B (zh) 2012-01-13 2017-04-05 通用医疗公司 麻醉剂化合物及其相关的使用方法
US10195288B2 (en) 2012-10-11 2019-02-05 Daiichi Sankyo Company, Limited Antibody-drug conjugate
JP6427789B2 (ja) 2013-07-23 2018-11-28 イミューノメディクス、インコーポレイテッドImmunomedics, Inc. Cl2aリンカーを有する抗体−sn−38免疫複合体
CA2920192A1 (en) * 2013-09-27 2015-04-02 Immunomedics, Inc. Anti-trop-2 antibody-drug conjugates and uses thereof
SG10201902571VA (en) * 2013-12-25 2019-04-29 Daiichi Sankyo Co Ltd Anti-trop2 antibody-drug conjugate
SG11201603960XA (en) 2014-01-31 2016-07-28 Daiichi Sankyo Co Ltd Anti-her2 antibody-drug conjugate
US11185594B2 (en) * 2014-04-10 2021-11-30 Daiichi Sankyo Company, Limited (Anti-HER2 antibody)-drug conjugate
EP3354649B1 (en) 2015-10-15 2019-12-04 Jiangsu Hengrui Medicine Co., Ltd. Oxa spiro derivative, preparation method therefor, and applications thereof in medicines
CN107446050A (zh) * 2017-08-11 2017-12-08 百奥泰生物科技(广州)有限公司 Trop2阳性疾病治疗的化合物及方法
CN119219654A (zh) * 2017-12-15 2024-12-31 四川科伦博泰生物医药股份有限公司 生物活性物偶联物及其制备方法和用途
JP7408646B2 (ja) * 2018-09-30 2024-01-05 ジエンス ハンソー ファーマスーティカル グループ カンパニー リミテッド 抗-b7h3抗体-エキサテカンアナログコンジュゲート及びその医薬用途
CN111689980A (zh) * 2019-05-26 2020-09-22 四川百利药业有限责任公司 一种喜树碱药物及其抗体偶联物
AU2020288275A1 (en) * 2019-06-06 2022-02-03 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Anti-B7-H4 antibody–drug conjugate and medicinal use thereof
AU2020402006A1 (en) * 2019-12-12 2022-07-07 Jiangsu Hengrui Medicine Co., Ltd. Anti-claudin antibody-drug conjugate and pharmaceutical use thereof
BR112022011632A2 (pt) * 2019-12-16 2022-10-04 Jiangsu Hengrui Medicine Co Conjugado análogo de anticorpo exatecano anti-cea e uso farmacêutico do mesmo
JP7821733B2 (ja) * 2020-01-22 2026-02-27 上海森輝医薬有限公司 エリブリン誘導体の薬物複合体、その調製方法及びその医薬的応用
WO2021190480A1 (zh) * 2020-03-24 2021-09-30 上海翰森生物医药科技有限公司 抗体-药物偶联物及其医药用途

Similar Documents

Publication Publication Date Title
JP2023505708A5 (cg-RX-API-DMAC7.html)
JP2023519261A5 (cg-RX-API-DMAC7.html)
JP2023506805A5 (cg-RX-API-DMAC7.html)
JP7641919B2 (ja) 抗b7-h4抗体-薬物コンジュゲート及びその医薬的使用
JP2022511351A5 (cg-RX-API-DMAC7.html)
TWI891749B (zh) 抗體-藥物偶聯物及其醫藥用途
JP2023535598A5 (cg-RX-API-DMAC7.html)
EP3678700B1 (en) Compounds for reducing the viscosity of biological formulations
JP2020509027A5 (cg-RX-API-DMAC7.html)
JP2019535254A5 (ja) 抗pd−l1抗体および変異型
WO2023217227A1 (zh) 喜树碱类衍生物及配体-药物偶联物
EP3186278A1 (en) Internalizing moieties for treatment of cancer
JP2018524394A5 (cg-RX-API-DMAC7.html)
TW202237191A (zh) 抗體-藥物結合物之用途
JP7292526B2 (ja) 操作された抗il-2抗体
CN111278861A (zh) Pd-l1抗体、其抗原结合片段及医药用途
CN116096896A (zh) 一种含抗体药物偶联物的药物组合物及其用途
AU2020225173A1 (en) Anti-PD-L1 antibody and use thereof
JP2025503493A5 (cg-RX-API-DMAC7.html)
KR20250127137A (ko) 항-cmet 항체, 항체-약물 접합체, 이의 제조 방법 및 용도
TW202506193A (zh) Trop2結合劑及其結合物
JP2024536798A5 (cg-RX-API-DMAC7.html)
JP2020507569A5 (cg-RX-API-DMAC7.html)
RU2022125170A (ru) Конъюгат антитела против PSMA и аналога эксатекана и его медицинское применение
JP2023500385A5 (cg-RX-API-DMAC7.html)